-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Trousseau's Syndrome: Management of Refractory VTE

Program: Education Program
Session: Challenges in Cancer-Associated Thrombosis
Sunday, December 8, 2024, 4:30 PM-5:45 PM

Jeffrey I. Zwicker, MD

Memorial Sloan Kettering, NYC, NY

Disclosures: Zwicker: Incyte Corporation: Research Funding; Quercegen: Research Funding; Parexel: Consultancy; Calyx: Consultancy; BMS: Consultancy; Regeneron: Consultancy, Research Funding; Med Learning Group: Consultancy; UpToDate: Patents & Royalties; CSL Behring: Other: Personal fees; Sanofi: Other: Personal fees.

See more of: Challenges in Cancer-Associated Thrombosis
See more of: Education Program
<< Previous Presentation | Next Presentation >>